Addressing Disparities in Cardio-Oncology
Cardio-oncology, the intersection of cardiology and oncology, plays a crucial role in managing cardiovascular complications in cancer patients undergoing treatment.
For the third edition of this series of weekly educational broadcasts, brought to you by IC-OS's partnership with Radcliffe, we delve into the critical issue of disparities within the field of cardio-oncology, how we can best understand and address these disparities, and explore potential solutions to bridge the gap.
Experts in this field, Dr Arnethea Sutton (VCU College of Humanities and Sciences, US) and Dr Khalid Matin (VCU Medical Center North Hospital, US), join us to share their insights on this important topic.
The partnership combines Radcliffe’s rapidly growing global community and expertise in delivering the most innovative virtual events, with the knowledge and experience of IC-OS’s members, to curate broadcasts that challenge current practice and have real-world patient benefits.
This broadcast is for cardiologists, haematologists, oncologists, nurse practitioners, nurses and pharmacists.
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS are collectively improving the overall outcomes including survival and quality of life. IC-OS aim to provide the latest scientific and clinical education and research for anyone treating patients with cancer in the hopes of enhancing cardiovascular protection.
This is an independent activity run by the International Cardio-Oncology Society (ICOS) and co-produced in collaboration with Radcliffe Cardiology. The IC-OS has been provided support to deliver this webinar series by AstraZeneca, BMS/Pfizer Alliance and Roche through an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity. Radcliffe Cardiology has received no industry funding.
This broadcast is supported by
Dr Arnethea Sutton is an Assistant Professor at VCU College of Humanities and Sciences, Richmond, US and also a member of the Cancer Prevention and Control research programme at VCU Massey Cancer Center.
She earned her Ph.D. in health-related sciences from VCU in 2017, and most recently completed a T32 postdoctoral fellowship in the Department of Health Behavior and Policy at VCU.
Dr Sutton studies the impact of sociodemographic, health care and psychosocial factors on racial disparities in cardiovascular toxicities experienced by breast cancer survivors.
Dr Khalid Matin is an Oncologist at VCU Medical Center North Hospital, Richmond, US. His focus is on GI cancers.
He coordinates the opening and closing of clinical trials at affiliate sites, including sites in Richmond and around the state of Virginia.
Dr Matin is also an active member of NRG Oncology's Colorectal Committee.
Prof Joe Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute and the Chief of Staff of the Abramson Cancer Center.
He is the Director of the Thalheimer Cardio-oncology Center at the Abramson Cancer Center and his clinical practice is in the subspecialty of cardio-oncology.
Prof Daniel Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, at Saint Francis Healthcare System, Cape Girardeau, US.
He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.
He is actively involved in patient care as the Director of the Cardio-Oncology Programme, Cardiac Rehabilitation, and the Heart Failure clinic at Saint Francis Healthcare System.
Dr Wendy Bottinor is a Cardio-oncologist at VCU Medical Center, Richmond, US.
She earned her medical degree and completed her internal medicine residency at Virginia Commonwealth University in Richmond, US.
Dr Bottinor is board certified in echocardiography and nuclear cardiology and has published on the role of echocardiography and novel echocardiographic techniques in preclinical detection of cancer-related cardiotoxicity.